Comprehensive PMHNP Certification Review Manual Study Guide

PREPARING FOR THE CERTIFICATION EXAMINATION

  • Controlling Anxiety:

    • Recognize that educational programs are specifically designed for exam preparation.

    • Instructors have typically taken similar exams and can provide guidance.

    • Success depends on setting up a study plan or taking a review course.

  • Managing Information and Expectations:

    • Avoid Gossip: Historical reports from peers are often unverifiable, inaccurate, and based on stress-induced memories. Blueprints ensure no single content area is overemphasized.

    • Entry-Level Threshold: The exam tests readiness for entry-level practice; a perfect score is not required. Focus on general rules and the "most likely" presentations rather than rare or atypical cases.

    • Depth of Knowledge: You cannot know everything. Knowledge should be sufficient for entry-level performance. Focus on drug categories, major indications, contraindications, and side effects rather than exact dosages.

  • Systematic Study Plan:

    • Organization: Schedule regular study times in one-hour increments; avoid cramming.

    • Materials: Pathophysiology text, review book, physical assessment text, class notes, and practice tests. Study body systems "head to toe."

    • Learning Styles: Listeners should attend courses; readers should review test facility materials multiple times.

    • Environment: Use a specific place with good lighting and no distractions.

  • Examination Logistics and Skills:

    • Timing: Average (45(45 to 60)60) seconds per question.

    • Multiple Choice Structure: 175 total questions; 150 are scored, 25 are pre-test pilot questions. Each question is independent (no multiple-multiples like "a and c").

    • Analysis Techniques:

      • Read the entire stem and all four options before selecting.

      • Identify keywords (e.g., initial, best, except, not).

      • If two options are opposite, one is likely correct.

      • If options are numeric, the middle range is often correct.

      • Avoid changing answers unless a compelling new realization occurs; first instincts are usually more accurate.

PMHNP ROLE, SCOPE OF PRACTICE, AND REGULATORY PROCESS

  • Foundations of the Role:

    • Emerged from 1950s work by June Mellow and Hildegard Peplau.

    • Integrates core Advanced Practice Registered Nurse (APRN) knowledge with specialized psychiatry content.

    • Prepare at master's or doctoral levels to provide primary psychiatric care across the life span.

  • Core Competencies (NONPF):

    • Scientific Foundations, Leadership, Quality, Practice Inquiry, Technology/Information Literacy, Policy, Health Delivery System, Ethics, and Independent Practice.

  • Regulatory and Statutory Dimensions:

    • Nurse Practice Act: State-specific legislation that grants legal authority, provides title protection, defines scope of practice, and sets credentialing requirements.

    • Licensure: Permission granted by the state to engage in a profession.

    • Certification: Process by which a professional organization (e.g., ANCC) certifies mastery of a specialized body of knowledge.

    • Credentialing: Protects the public by ensuring a minimum level of professional competence.

    • Collaborative Agreement: A protocol describing prescription oversight and physician collaboration required by some states.

  • Professional Responsibilities and Ethics:

    • Confidentiality: Protected by the Medical Record Confidentiality Act (19951995). Pertains to both verbal and written data. Exceptions include Tarasoff (Duty to Warn), child/elder abuse, and legal summons.

    • HIPAA Rights: Access to records, educational rights regarding privacy, ability to request amendments, and disclosure control.

    • Informed Consent: Communication process resulting in acceptance or rejection of treatment. Must include nature/purpose, risks/benefits, and alternatives.

    • Ethical Principles:

      • Justice: Fairness.

      • Beneficence: Promoting good.

      • Nonmaleficence: Doing no harm.

      • Fidelity: Loyalty.

      • Autonomy: Self-directed care.

      • Veracity: Truth-telling.

    • Theoretical Approaches:

      • Deontological: Judging acts by the act itself regardless of outcome.

      • Teleological: Judging by the consequence.

      • Virtue Ethics: Judging by the moral character of the person.

  • Legal Considerations:

    • Malpractice Negligence (Four Elements):

      1. Duty: Exercising reasonable care.

      2. Breach of Duty: Violation of standards.

      3. Proximate Cause: Causal relationship to injury.

      4. Damages: Permanent/substantial injury.

    • Commitment: Involuntary admission requires a diagnosed disorder, harm to self/others, and lack of insight where treatment would improve functioning.

THEORETICAL BASIS OF CARE

  • Biopsychosocial Framework:

    • Recovery: Dimensions include health, home, purpose, and community.

    • DSM-5: Shifted from multiaxial to reliability-tested criteria and dimensional assessments.

  • Therapeutic Relationship Phases:

    • Introduction (Orientation): Trust, boundaries, treatment objectives.

    • Working (Identification/Exploitation): Plan implementation, preventative care, measuring outcomes.

    • Termination (Resolution): Disengaging, referral, progress review.

  • Key Developmental Theories:

    • Erikson (Psychosocial): Eight stages from Trust vs. Mistrust (infancy) to Integrity vs. Despair (late adulthood).

    • Freud (Psychosexual): Focus on Id, Ego, Superego. Includes stages: Oral, Anal, Phallic, Latency, Genital.

    • Piaget (Cognitive): Sensorimotor (0−20-2 years), Preoperational (2−72-7), Concrete Operations (7−127-12), Formal Operations (12+12+).

    • Sullivan (Interpersonal): Behavior results from interpersonal dynamics. Mental illness occurs when satisfaction and security needs are blocked.

    • Maslow (Hierarchy): Survival > Safety > Love/Belonging > Self-esteem > Self-actualization.

  • Behavioral Change Theories:

    • Health Belief Model: Focuses on perceptions of susceptibility and barriers to change.

    • Transtheoretical Model (Stages of Change): Precontemplation, Contemplation, Preparation, Action, Maintenance.

  • Nursing Specific Theories:

    • Leininger: Transcultural nursing; care is the essence.

    • Orem: Self-care maintenance.

    • Peplau: Nursing as an interpersonal process; focus on adaptive responses.

    • Watson: "Carative factors" potentiating healing.

NEUROANATOMY, NEUROPHYSIOLOGY, AND BEHAVIOR

  • Brain Structure:

    • Frontal Lobe: Executive functions, Broca's area (expressive speech), motor function.

    • Temporal Lobe: Wernicke’s area (language comprehension), memory, auditory area.

    • Occipital Lobe: Primary visual cortex.

    • Parietal Lobe: Sensory area, taste, reading/writing.

    • Limbic System: Modulates emotions/memory. Consists of Hypothalamus (regulatory), Thalamus (sensory relay), Hippocampus (long-term memory conversion), and Amygdala (mood, fear, aggression).

    • Basal Ganglia: Movement initiation, extrapyramidal motor system.

  • Neurotransmission:

    • Action Potential: Depolarization (Sodium/Calcium enter cell); Repolarization (Potassium leaves/Chloride enters).

    • Monoamines:

      • Dopamine: Catecholamine. Schizophrenia-related (excess or deficit).

      • Norepinephrine: Implicated in mood/anxiety.

      • Serotonin (Indole): Implicated in sleep, aggression, and mood.

    • Amino Acids:

      • Glutamate: Excitatory neurotransmitter.

      • GABA: Inhibitory neurotransmitter; benzodiazepine target.

  • Genomics:

    • Pedigree: Visual family tree (33 generations) for risk assessment.

    • Heritability: Ranges from 40%40\% to 90%90\% for disorders like Bipolar and ADHD.

    • HLA-B*1502 Allele: Asians must be screened for this before taking Carbamazepine due to SJS/TEN risk.

ADVANCED HEALTH AND PHYSICAL ASSESSMENT

  • Neuro-Specific Exams:

    • Cranial Nerves: 1-Olfactory, 2-Optic, 3-Oculomotor, 4-Trochlear, 5-Trigeminal, 6-Abducens, 7-Facial, 8-Acoustic, 9-Glossopharyngeal, 10-Vagus, 11-Accessory, 12-Hypoglossal.

    • Neurological Soft Signs: Dysdiadochokinesia (alternating movements), Astereognosis (tactile recognition), Graphesthesia (writing on skin recognition).

  • Laboratory Significance:

    • Thyroid: Low T<em>4T<em>4/High TSH mimics depression; High T</em>4T</em>4/Low TSH mimics Bipolar mania.

    • Electrolytes:

      • Calcium: Normal (8.8−10.5)(8.8-10.5) mg/dl. High Ca can cause lethargy/constipation; Low Ca can cause tetany and prolonged QT interval.

      • Sodium: Normal (135−148)(135-148) mEq/L. Low Na (hyponatremia) is a risk with SSRIs, causing confusion/seizures.

      • Potassium: Normal (3.5−5.1)(3.5-5.1) mEq/L. Hyperkalemia (High K) causes narrow/tall T-waves.

    • Liver: AST/ALT monitoring for hepatotoxic drugs (Valproic acid). GGT is used to screen for alcohol abuse.

  • Public Health Principles:

    • Primary Prevention: Reducing incidence (new cases). e.g., parenting classes.

    • Secondary Prevention: Reducing prevalence (existing cases). e.g., Hotlines, screening.

    • Tertiary Prevention: Reducing disability/severity. e.g., rehab services, case management.

PHARMACOLOGICAL PRINCIPLES

  • Pharmacokinetics:

    • Process: Absorption -> Distribution -> Metabolism -> Excretion.

    • Half-life determines steady state (approx. 55 half-lives).

    • Older adults have higher body fat and lower protein, leading to increased levels of free drug (lipophilic drugs).

  • Pharmacodynamics:

    • Agonist: Activates biological response.

    • Antagonist: Blocks response.

    • Therapeutic Index: Large distances between effective and toxic doses are safe (Divalproex); short distances are narrow (Lithium (0.5−1.2)(0.5-1.2) mEq/L).

  • Teratogenic Risks:

    • Benzodiazepines: Cleft palate/Floppy baby.

    • Carbamazepine: Neural tube defects.

    • Lithium: Ebstein anomaly (cardiac).

    • Valproic acid: Spina bifida.

CLINICAL MANAGEMENT OF SPECIFIC DISORDERS

  • Depressive Disorders:

    • MDD: First-line: SSRIs. Combined with psychotherapy. Continue for 6−126-12 months after remission.

    • MAOIs: Require tyramine-free diet to avoid hypertensive crisis (sudden occipitial headache).

    • Serotonin Syndrome: Autonomic instability, myoclonus, hyperreflexia.

  • Bipolar Disorders:

    • Lithium: Gold standard. Requires baseline renal and thyroid testing.

    • Anticonvulsants: Divalproex (loading dose 2020 mg/kg), Carbamazepine (risk of aplastic anemia), Lamotrigine (slow titration to avoid SJS).

  • Schizophrenia Spectrum:

    • Dopamine Pathways:

      • Mesolimbic: High DA = Positive symptoms.

      • Mesocortical: Low DA = Negative symptoms.

    • Atypical Antipsychotics: SDA (Serotonin-Dopamine Antagonists). Clozapine requires ANC (Absolute Neutrophil Count) monitoring due to agranulocytosis risk.

    • Typical Antipsychotics: High EPSE risk (Dystonia, Akathisia, TD).

  • Substance-Related Disorders:

    • Alcohol Withdrawal: High mortality. Treat with Benzodiazepine taper. Score using CIWA-Ar scale.

    • Sobriety Management: Disulfiram (Avoid alcohol for 1212 hours before and 22 weeks after); Naltrexone (opiate antagonist/anticraving).

  • Childhood/Adolescence:

    • ADHD: Stimulants (Schedule II) are first-line. Atomoxetine is non-stimulant alternative.

    • ODD vs Conduct: ODD is defiant toward authority; Conduct involves violating rights of others/animals and property destruction.

    • Autism Spectrum (ASD): Deficits in social reciprocity and repetitive behavior patterns.

VIOLENCE AND LETHALITY ASSESSMENT

  • Intimate Partner Violence (IPV): Abuser seeks power/control. Leading cause of injury to women 15−4415-44.

  • Lethality Assessment:

    • High Lethality: Jumping, guns, hanging.

    • Low Lethality: Superficial cutting, breath-holding.

  • Suicide Risk factors: Male gender, white, age 85+85+, living alone, depression, previous attempt.

  • Homicide Signs: Fascination with weapons, workplace loners, paranoid behavior.